Trial Profile
An Exploratory Study of an Active Ingredient of JNS013-Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2010
Price :
$35
*
At a glance
- Drugs Tramadol (Primary)
- Indications Back pain; Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 28 Apr 2010 Actual patient number (119) added as reported by ClinicalTrials.gov.
- 29 Sep 2008 New trial record.